Farallon Capital Management’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95.2K | Hold |
10,000
| – | – | ﹤0.01% | 125 |
|
|
2025
Q1 | $105K | Sell |
10,000
-219,121
| -96% | -$2.29M | ﹤0.01% | 128 |
|
|
2024
Q4 | $5.4M | Sell |
229,121
-198,879
| -46% | -$4.69M | 0.02% | 79 |
|
|
2024
Q3 | $15.4M | Buy |
428,000
+422,000
| +7,033% | +$15.2M | 0.07% | 77 |
|
|
2024
Q2 | $212K | Buy |
+6,000
| New | +$212K | ﹤0.01% | 128 |
|
|
2020
Q4 | – | Sell |
-200,000
| Closed | -$4.04M | – | 141 |
|
|
2020
Q3 | $4.04M | Buy |
+200,000
| New | +$4.04M | 0.03% | 112 |
|